These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8533540)

  • 21. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug.
    Savarese JJ; Ali HH; Basta SJ; Embree PB; Scott RP; Sunder N; Weakly JN; Wastila WB; el-Sayad HA
    Anesthesiology; 1988 May; 68(5):723-32. PubMed ID: 2967039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination.
    Kim KS; Chun YS; Chon SU; Suh JK
    Anaesthesia; 1998 Sep; 53(9):872-8. PubMed ID: 9849281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time course of action and intubating conditions following vecuronium, rocuronium and mivacurium.
    Wierda JM; Hommes FD; Nap HJ; van den Broek L
    Anaesthesia; 1995 May; 50(5):393-6. PubMed ID: 7793541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mivacurium chloride administration by infusion.
    Apfelbaum JL
    Acta Anaesthesiol Scand Suppl; 1995; 106():55-7. PubMed ID: 8533547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The potency of mixtures of mivacurium and atracurium or vecuronium.
    Kopman AF
    Anesth Analg; 1995 Jul; 81(1):207-8. PubMed ID: 7598267
    [No Abstract]   [Full Text] [Related]  

  • 26. Interactions between suxamethonium and mivacurium or atracurium.
    Kim KS; Na DJ; Chon SU
    Br J Anaesth; 1996 Nov; 77(5):612-6. PubMed ID: 8957977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical and basic pharmacology of mivacurium: a short-acting nondepolarizing benzylisoquinolinium diester neuromuscular blocking drug.
    Savarese JJ; Lien CA; Belmont MR; Rubin L
    Acta Anaesthesiol Scand Suppl; 1995; 106():18-22. PubMed ID: 8533538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is intramuscular mivacurium an alternative to intramuscular succinylcholine?
    Cauldwell CB; Lau M; Fisher DM
    Anesthesiology; 1994 Feb; 80(2):320-5. PubMed ID: 8311314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuromuscular effects of mivacurium in 2- to 12-yr-old children with burn injury.
    Martyn JA; Goudsouzian NG; Chang Y; Szyfelbein SK; Schwartz AE; Patel SS
    Anesthesiology; 2000 Jan; 92(1):31-7. PubMed ID: 10638896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Edrophonium increases mivacurium concentrations during constant mivacurium infusion, and large doses minimally antagonize paralysis.
    Hart PS; Wright PM; Brown R; Lau M; Sharma ML; Miller RD; Gruenke L; Fisher DM
    Anesthesiology; 1995 Apr; 82(4):912-8. PubMed ID: 7717563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New skeletal muscle relaxants.
    Caldwell JE
    Int Anesthesiol Clin; 1995; 33(1):39-60. PubMed ID: 7635557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combinations of high-dose vecuronium and mivacurium provide similar paralysis and intubation conditions to succinylcholine in paediatric patients.
    Theroux MC; Brandom BW; Zagnoev MM; Drago L
    Paediatr Anaesth; 1996; 6(6):453-8. PubMed ID: 8936542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergism between atracurium and mivacurium compared with that between vecuronium and mivacurium.
    Jalkanen L; Meretoja OA; Taivainen T; Brandom BW; Dayal B
    Anesth Analg; 1994 Nov; 79(5):998-1002. PubMed ID: 7978423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of tracheal intubating conditions and neuromuscular blocking profiles after intubating doses of mivacurium chloride or succinylcholine in surgical outpatients.
    Goldberg ME; Larijani GE; Azad SS; Sosis M; Seltzer JL; Ascher J; Weakly JN
    Anesth Analg; 1989 Jul; 69(1):93-9. PubMed ID: 2525886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recovery of mivacurium and doxacurium versus vecuronium in the isolated forearm.
    Campkin NT; Hood JR; Feldman SA
    Anaesthesia; 1994 Jun; 49(6):501-2. PubMed ID: 7912478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Newer neuromuscular blocking drugs. An overview of their clinical pharmacology and therapeutic use.
    Mirakhur RK
    Drugs; 1992 Aug; 44(2):182-99. PubMed ID: 1382013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recovery from mivacurium block with or without anticholinesterase following continuous infusion in obstetric patients.
    Jan GS; Tong WN; Chan AM; Hui TW; Lo JW
    Anaesth Intensive Care; 1996 Oct; 24(5):585-9. PubMed ID: 8909671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The infusion rate of mivacurium or atracurium for cesarean section compared with gynecological procedures.
    Kim JH; Min KT; Ahn EK; Kim KH; Shin YS
    Yonsei Med J; 1999 Aug; 40(4):371-6. PubMed ID: 10487141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update on newer neuromuscular blocking drugs.
    Holm H; Ostergaard D
    Ann Acad Med Singap; 1994 Nov; 23(6 Suppl):108-13. PubMed ID: 7710219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mivacurium: dose-response relationship and administration by repeated injection or infusion.
    Diefenbach C; Mellinghoff H; Lynch J; Buzello W
    Anesth Analg; 1992 Mar; 74(3):420-3. PubMed ID: 1311535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.